Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID) - Agafina, Alina; Aguiar, Valeria Cristina; Rossovskaya, Maria; Fartoukh, Muriel Sarah; Hajjar, Ludhmila Abrahão; Thiery, Guillaume; Timsit, Jean-Francois; Gordeev, Ivan; Protsenko, Denis; Carbone, Javier (European Journal of Medical Research, 2024)